Tatva Chintan FY26 Revenue Up 32%, PAT Surges 636%

Tatva Chintan reported FY26 consolidated revenue of ₹5,059 Mn, up 32% YoY, with PAT surging 636% to ₹421 Mn.
Q4FY26 revenue grew 24% YoY to ₹1,341 Mn, with PAT increasing 902% to ₹103 Mn, driven by strong SDA and PTC performance.
The company operates as an integrated specialty chemical manufacturer with 75% export revenue and a focus on green chemistry processes like electrolysis.
Key products include Structure Directing Agents (41% of revenue), Phase Transfer Catalysts (23%), and Pharmaceutical Intermediates (32%).